Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lemaitre Vascular Inc Issues Q2 2013 Guidance Above Analysts' Estimates; Raises FY 2013 Revenue Guidance; Reaffirms FY 2013 Operating Income Guidance


Tuesday, 30 Apr 2013 04:30pm EDT 

Lemaitre Vascular Inc announced that for the second quarter of 2013, it expects sales of $15.6 million, and operating income of $1.2 million. The Company also announced that it increased its fiscal 2013 sales guidance to $61.7 million and maintained its operating income guidance of $5.0 million. All guidance excludes the effects of changes in foreign currency exchange rates, acquisitions and divestitures. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $15.5 million and EBIT of $1.1 million for the second quarter of 2013; revenues of $61.2 million and EBIT of $4.43 million for fiscal 2013. 

Company Quote

7.44
0.03 +0.40%
4:00pm EDT